News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
635,377 Results
Type
Article (52008)
Company Profile (398)
Press Release (582971)
Multimedia
Podcasts (95)
Webinars (12)
Section
Business (165840)
Career Advice (3089)
Deals (30259)
Drug Delivery (105)
Drug Development (79886)
Employer Resources (176)
FDA (15230)
Job Trends (13337)
News (297026)
Policy (29116)
Tag
Academia (2840)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (89)
Alliances (44608)
ALS (94)
Alzheimer's disease (1444)
Antibody-drug conjugate (ADC) (143)
Approvals (15202)
Artificial intelligence (271)
Autoimmune disease (27)
Automation (15)
Bankruptcy (294)
Best Places to Work (10999)
BIOSECURE Act (22)
Biosimilars (101)
Biotechnology (305)
Bladder cancer (84)
Brain cancer (30)
Breast cancer (292)
Cancer (2340)
Cardiovascular disease (189)
Career advice (2605)
Career pathing (33)
CAR-T (173)
Cell therapy (483)
Cervical cancer (21)
Clinical research (64641)
Collaboration (873)
Company closure (1)
Compensation (511)
Complete response letters (27)
COVID-19 (2630)
CRISPR (47)
C-suite (247)
Cystic fibrosis (107)
Data (2228)
Decentralized trials (2)
Denatured (28)
Depression (51)
Diabetes (280)
Diagnostics (5727)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (44)
Drug discovery (128)
Drug pricing (107)
Drug shortages (31)
Duchenne muscular dystrophy (101)
Earnings (61862)
Editorial (45)
Employer branding (21)
Employer resources (153)
Events (106927)
Executive appointments (695)
FDA (16486)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (779)
Gene editing (117)
Generative AI (24)
Gene therapy (355)
GLP-1 (762)
Government (4434)
Grass and pollen (5)
Guidances (59)
Healthcare (18388)
Huntington's disease (23)
IgA nephropathy (30)
Immunology and inflammation (137)
Indications (30)
Infectious disease (2766)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (48)
Intellectual property (97)
Interviews (599)
IPO (14644)
IRA (45)
Job creations (2783)
Job search strategy (2134)
Kidney cancer (10)
Labor market (36)
Layoffs (448)
Leadership (23)
Legal (6077)
Liver cancer (72)
Lung cancer (328)
Lymphoma (155)
Machine learning (7)
Management (62)
Manufacturing (322)
MASH (71)
Medical device (11868)
Medtech (11871)
Mergers & acquisitions (16203)
Metabolic disorders (729)
Multiple sclerosis (80)
NASH (21)
Neurodegenerative disease (102)
Neuropsychiatric disorders (33)
Neuroscience (2016)
NextGen: Class of 2025 (6364)
Non-profit (4489)
Now hiring (31)
Obesity (389)
Opinion (262)
Ovarian cancer (76)
Pain (97)
Pancreatic cancer (77)
Parkinson's disease (155)
Partnered (20)
Patents (231)
Patient recruitment (112)
Peanut (49)
People (49390)
Pharmaceutical (78)
Pharmacy benefit managers (20)
Phase I (20357)
Phase II (28613)
Phase III (21239)
Pipeline (1208)
Policy (156)
Postmarket research (2360)
Preclinical (8749)
Press Release (68)
Prostate cancer (112)
Psychedelics (37)
Radiopharmaceuticals (265)
Rare diseases (421)
Real estate (5109)
Recruiting (70)
Regulatory (20743)
Reports (36)
Research institute (2525)
Resumes & cover letters (496)
Rett syndrome (5)
RNA editing (5)
RSV (39)
Schizophrenia (78)
Series A (135)
Series B (87)
Service/supplier (9)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (153)
Sponsored (33)
Startups (3317)
State (2)
Stomach cancer (16)
Supply chain (68)
Tariffs (39)
The Weekly (66)
Vaccines (689)
Venture capitalists (43)
Weight loss (269)
Women's health (31)
Worklife (20)
Date
Today (144)
Last 7 days (910)
Last 30 days (2592)
Last 365 days (32747)
2025 (10748)
2024 (34967)
2023 (39159)
2022 (49450)
2021 (53750)
2020 (51556)
2019 (44513)
2018 (33668)
2017 (31117)
2016 (30659)
2015 (35300)
2014 (27522)
2013 (22628)
2012 (23871)
2011 (24317)
2010 (22147)
Location
Africa (877)
Alabama (55)
Alaska (7)
Arizona (174)
Arkansas (14)
Asia (37595)
Australia (6725)
California (5980)
Canada (1947)
China (535)
Colorado (256)
Connecticut (270)
Delaware (145)
Europe (87011)
Florida (875)
Georgia (198)
Idaho (52)
Illinois (538)
India (26)
Indiana (278)
Iowa (10)
Japan (158)
Kansas (102)
Kentucky (26)
Louisiana (11)
Maine (49)
Maryland (856)
Massachusetts (4680)
Michigan (210)
Minnesota (369)
Mississippi (1)
Missouri (79)
Montana (28)
Nebraska (21)
Nevada (53)
New Hampshire (61)
New Jersey (1693)
New Mexico (30)
New York (1727)
North Carolina (995)
North Dakota (8)
Northern California (2600)
Ohio (199)
Oklahoma (15)
Oregon (34)
Pennsylvania (1347)
Puerto Rico (11)
Rhode Island (32)
South America (1160)
South Carolina (21)
Southern California (2240)
Tennessee (81)
Texas (863)
United States (22711)
Utah (160)
Virginia (146)
Washington D.C. (63)
Washington State (566)
West Virginia (3)
Wisconsin (51)
635,377 Results for "the wistar institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
IMUNON Enters into Collaborative Research Agreement with The Wistar Institute’s Vaccine & Immunotherapy Center to Research IMUNON’s PLACCINE Vaccine Platform
IMUNON, Inc., a clinical-stage drug development company, and The Wistar Institute, a global leader in biomedical research located in the heart of University City, Philadelphia, through its Vaccine & Immunotherapy Center, announce the signing of a first collaborative research agreement to research and develop new vaccine formulations utilizing IMUNON’s PLACCINE modality for the development of vaccines for infectious diseases.
January 5, 2023
·
4 min read
Pharm Country
Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics
Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.
May 17, 2024
·
3 min read
Press Releases
Joseph Spine Institute Launches Center for Regenerative Spine Medicine, Pioneering Advanced Stem Cell Therapy
April 10, 2025
·
2 min read
Pharm Country
Independent Lab Confirms Immunogenicity and Protection with IMUNON’s IMNN-101 in a Live Virus Challenge Against SARS-CoV-2 Variant XBB.1.5
IMUNON, Inc. announces positive results from a live virus challenge study conducted for IMUNON by the Wistar Institute with IMNN-101 against the SARS-CoV-2 variant XBB.1.5.
February 29, 2024
·
4 min read
Press Releases
Thermo Fisher Scientific and Chan Zuckerberg Institute for Advanced Biological Imaging Collaborate to Further Understanding of Human Cells
March 28, 2025
·
4 min read
Press Releases
The NIMML Institute and NImmune Biopharma Showcase How the TITAN-X A.I. Platform has Accelerated Therapeutic Development in the Annual Review of Biomedical Data Science
April 21, 2025
·
6 min read
Press Releases
Quantum Computing, Inc. Announces Collaboration with Sanders Tri-Institutional Therapeutics Discovery Institute To Support Research Using Dirac-3 Systems
January 15, 2025
·
4 min read
Press Releases
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
April 28, 2025
·
2 min read
Press Releases
Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million
March 27, 2025
·
2 min read
Press Releases
Argobio and the Institut Pasteur Launch Enodia Therapeutics: A Biotech Company With a New Approach for Targeted Protein Degradation
February 26, 2025
·
5 min read
1 of 63,538
Next
